CFO departure
Insmed Incorporated discloses CFO departure: Sara Bonstein
Insmed Incorporated reported in a Form 8-K filed October 5, 2026 a change involving its Chief Financial Officer, Sara Bonstein, effective October 30, 2026. The filing's own words are quoted below.
In the filing's words
On October 5, 2026, Insmed Incorporated (the “Company”) announced that Sara Bonstein, the Company’s Chief Financial Officer, would be separating from the Company, effective October 30, 2026, and the Company has a search underway to identify a successor.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Insmed Incorporated (INSM) |
|---|---|
| Event | Departure |
| Outgoing | Sara Bonstein |
| Effective | October 30, 2026 |
| 8-K filed | October 5, 2026 |
| SEC CIK | 0001104506 |
Insmed Incorporated reported this change in a Form 8-K, Item 5.02, filed October 5, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-10-06
Something wrong about Sara Bonstein? Send a correction with the primary source.